Akebia Therapeutics
(AKBA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 6,899 | 6,359 | 6,112 | -69,410 | -46,606 |
| Depreciation Amortization | 948 | 630 | 314 | 41,702 | 28,159 |
| Accounts receivable | -33,240 | -39,400 | -27,872 | 4,046 | 7,120 |
| Other Working Capital | -5,399 | -24,626 | -29,726 | -39,676 | -36,445 |
| Other Operating Activity | 67,655 | 65,795 | 37,585 | 22,679 | 11,579 |
| Operating Cash Flow | $36,863 | $8,758 | $-13,587 | $-40,659 | $-36,193 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -49 | 28 | 154 | -33 | -31 |
| Investing Cash Flow | $-49 | $28 | $154 | $-33 | $-31 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,000 | 10,000 | 10,000 | 45,000 | 45,000 |
| Debt Repayment | -462 | -462 | -462 | -37,099 | -37,100 |
| Common Stock Issued | 68,300 | 67,187 | 65,467 | 43,034 | 20,710 |
| Other Financing Activity | -63 | -63 | -63 | -1,272 | -1,272 |
| Financing Cash Flow | $77,775 | $76,662 | $74,942 | $49,663 | $27,338 |
| Beginning Cash Position | 53,550 | 53,550 | 53,550 | 44,579 | 44,579 |
| End Cash Position | 168,139 | 138,998 | 115,059 | 53,550 | 35,693 |
| Net Cash Flow | $114,589 | $85,448 | $61,509 | $8,971 | $-8,886 |
| Free Cash Flow | |||||
| Operating Cash Flow | 36,863 | 8,758 | -13,587 | -40,659 | -36,193 |
| Capital Expenditure | -221 | -144 | -18 | -33 | -31 |
| Free Cash Flow | 36,642 | 8,614 | -13,605 | -40,692 | -36,224 |